Does amniotic fluid alpha-fetoprotein have diagnostic or prognostic value at the time of second midtrimester genetic amniocentesis?

G. P. Mandruzzato, L. Fischer-Tamaro, F. De Seta, G. D'Ottavio, M. A. Rustico, G. Conoscenti, Y. L. Meir, R. Pinzano, G. Maso, A. Grasso, C. Gigli

Research output: Contribution to journalArticlepeer-review

Abstract

In order to assess the usefulness of amniotic fluid α-fetoprotein (AFP) levels at the time of midtrimester genetic amniocentesis, 4,430 cases were retrospectively studied to compare the high, normal or low AFP values with the karyotype characteristics and fetal anatomy using ultrasound (US) scanning and confirmed by postnatal evaluation or necroscopy in the case of termination of pregnancy. All the cases presenting malformations were correctly diagnosed by US examinations. AFP levels over the 2nd standard deviation (SD) were found in 112 cases (2.52%) and below the 2nd SD in 11 cases (0.24%). The characteristics of these cases are presented and discussed. According to our results, it is concluded that routine assessment of AFP at the time of midtrimester genetic amniocentesis, if coupled with optimal US scanning, is no longer justified.

Original languageEnglish
Pages (from-to)147-152
Number of pages6
JournalFetal Diagnosis and Therapy
Volume17
Issue number3
DOIs
Publication statusPublished - 2002

Keywords

  • α-Fetoprotein
  • Amniocentesis
  • Amniotic fluid
  • Chromosomes
  • Malformations
  • Ultrasound

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Pediatrics, Perinatology, and Child Health

Fingerprint

Dive into the research topics of 'Does amniotic fluid alpha-fetoprotein have diagnostic or prognostic value at the time of second midtrimester genetic amniocentesis?'. Together they form a unique fingerprint.

Cite this